Mepolizumab improves sino-nasal symptoms and asthma control in severe eosinophilic asthma patients with chronic rhinosinusitis and nasal polyps: a 12-month real-life study

BACKGROUND: Severe eosinophilic asthma is frequently associated to chronic rhinosinusitis and nasal polyposis (CRSwNP) that contribute to poor asthma control. Mepolizumab is an anti-IL-5 monoclonal antibody, approved for the treatment of severe eosinophilic asthma. A limited number of studies have a...

Descripción completa

Detalles Bibliográficos
Autores principales: Detoraki, Aikaterini, Tremante, Eugenio, D’Amato, Maria, Calabrese, Cecilia, Casella, Claudia, Maniscalco, Mauro, Poto, Remo, Brancaccio, Raffaele, Boccia, Matilde, Martino, Maria, Imperatore, Clara, Spadaro, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107661/
https://www.ncbi.nlm.nih.gov/pubmed/33910399
http://dx.doi.org/10.1177/17534666211009398

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107661/
https://www.ncbi.nlm.nih.gov/pubmed/33910399
http://dx.doi.org/10.1177/17534666211009398

Ejemplares similares